NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,358,659 | +27.7% | 146,047 | +228.2% | 0.01% | -14.3% |
| Q2 2023 | $1,846,750 | +42.8% | 44,500 | +107.0% | 0.01% | -63.2% |
| Q1 2023 | $1,293,010 | +102.4% | 21,500 | +146.9% | 0.02% | +58.3% |
| Q4 2022 | $638,732 | -35.8% | 8,708 | -33.5% | 0.01% | -36.8% |
| Q3 2022 | $995,000 | +380.7% | 13,100 | +340.8% | 0.02% | +216.7% |
| Q2 2022 | $207,000 | -12.7% | 2,972 | +39.7% | 0.01% | -76.9% |
| Q3 2020 | $237,000 | -84.0% | 2,128 | -89.3% | 0.03% | -70.8% |
| Q3 2019 | $1,481,000 | +12.5% | 19,804 | -4.9% | 0.09% | -38.6% |
| Q2 2019 | $1,317,000 | +24.8% | 20,833 | -4.9% | 0.14% | -16.7% |
| Q1 2019 | $1,055,000 | – | 21,910 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |